About

Kirk Evoy, Pharm.D., BCACP, BC-ADM, CTTS, FCCP, FTSHP, is a Clinical Associate Professor in the Pharmacotherapy Division of the College of Pharmacy at The University of Texas at Austin and an Adjoint Associate Professor in the School of Medicine at the University of Texas Health San Antonio. He also serves as an ambulatory care clinical pharmacist at University Health in San Antonio. Dr. Evoy completed his pre-pharmacy and Doctor of Pharmacy coursework at Purdue University, followed by a PGY1 Pharmacy Practice Residency at the University of Wisconsin Hospital and Clinics and a PGY2 Ambulatory Care Residency at Saint Joseph Regional Medical Center. He has completed two teaching certificate programs and a Certificate of Added Training in Global Health, and holds board certifications as an Ambulatory Care Pharmacist, Advanced Diabetes Manager, and Tobacco Treatment Specialist. His primary research interests include substance use disorders and smoking cessation, with clinical focus on primary care, diabetes management, and transitions of care. His research program aims to improve health outcomes for patients with substance use disorders, emphasizing emerging trends in prescription drug misuse, opioid overdose prevention, and research related to vaping, kratom, and hemp-derived cannabinoids. Dr. Evoy is dedicated to fostering early student research opportunities, particularly community service learning projects that combine research training with initiatives to enhance local community health.

Research topics

• Medicine
• Internal medicine
• Emergency medicine
• Medical emergency
• Family medicine
• Business
• Psychiatry
• Pathology

Selected publications

• Increasing Buprenorphine and Naloxone Access in Texas Community Pharmacies Through an Academic Detailing Intervention

  Substance Use &amp Addiction Journal · 2026-03-17

  articleOpen access

  Background: Patients with opioid use disorder need prompt buprenorphine/naloxone (BUP/NX) and naloxone nasal spray (NNS) access from pharmacies, but audit studies report substantial availability deficits. No specific intervention has increased BUP/NX stocking, and little is known about the impact of transitioning specific NNS formulations to over-the-counter. The purpose of this study was to assess the impact of mailed academic detailing on BUP/NX availability and the ability to obtain NNS without a prescription. Methods: A prospective interventional study was conducted in a sample of 1000 Texas community pharmacies assigned 1:1 to intervention and control groups. The intervention group received academic detailing handouts with links to continuing education addressing BUP/NX and NNS. Pre- and post-intervention audits were conducted using a telephonic secret-shopper approach. Outcomes for BUP/NX included stocking, willingness to order if not stocked, and a composite outcome of stocking and willingness to order. NNS outcomes included availability without a prescription. McNemar and Wilcoxon signed-rank tests, and generalized estimating equations (GEE) were used for analyses. Results: Data from 757 pharmacies were included in analyses (374 intervention, 383 control). Baseline BUP/NX stocking was low (36.7%) with no statistically significant pre-to-post changes for either group. Most pharmacies were willing to order (60.5%) with no significant pre-to-post changes for either group. GEE analysis found no significant difference in odds of stocking between groups (aOR = 1.08, P = .73), but the intervention group had a significantly higher likelihood to order (aOR = 2.25, P = .02) and of achieving the composite outcome (aOR = 2.17, P = .01). NNS availability increased in both groups but did not differ significantly between groups (aOR = 1.00, P = .99). Conclusions: A mailed academic detailing intervention did not change NNS availability or BUP/NX stocking but did modestly increase willingness to order BUP/NX. This intervention is easily replicable and scalable, but modifications to increase the magnitude of its effect are needed.

  PublisherDOI

• Comment on “Adopting Race‐Free Estimated Glomerular Filtration Rate for Unifying Medication‐Related Decision‐Making: An Opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy”

  JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · 2026-03-18

  article
  PublisherDOI

• Embracing Pharmacists' Opportunities to Improve Care for People Living With Substance Use Disorders

  JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · 2026-02-27

  article1st authorCorresponding

  Kirk E. Evoy and Paul M. Stranges are members of the JACCP Editorial Board.

  PublisherDOI

• A novel clinical interprofessional education experience between pharmacy and dental students in an advanced geriatric surgical dental clinic

  JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · 2025-07-01 · 1 citations

  articleOpen access

  Abstract Introduction To address the opioid crisis in the United States, guidelines have prioritized non‐opioid therapies (i.e., non‐steroidal anti‐inflammatory drugs, acetaminophen), for postoperative dental pain. Complex cases may necessitate alternative analgesics, requiring careful pharmacotherapy management. Integrating pharmacists into dental care teams can optimize pain management and patient outcomes. This study evaluated a clinical interprofessional education (IPE) experience involving pharmacy and dental students in a geriatric oral surgery clinic. The objectives were to enhance students' knowledge and skills in managing postoperative pain and evaluate interprofessional behaviors within a clinical learning environment. Methods From 2020 to 2022, third‐year pharmacy and dental students collaborated weekly in a geriatric oral surgery clinic which provided advanced dental procedures. Before clinic integration, students underwent a comprehensive orientation, including an IPE overview and profession‐specific student‐led trainings. Students collaboratively developed management plans integrating surgical and pharmacologic interventions. The Individual Teamwork Observation and Feedback Tool (iTOFT) was used to assess pharmacy student interactions. Pre‐ and post‐assessments evaluated students' pain management knowledge. A debriefing survey captured students' perceptions of pharmacy‐dental clinical collaborations. Results Fifteen pharmacy and 33 dental students participated. iTOFT evaluations for pharmacy students highlighted strengths in shared decision‐making and patient‐centered care but revealed opportunities for improved team collaboration. Pharmacy students showed significant improvement in pain management knowledge (56.3% to 75%, p = 0.0137), while dental students' knowledge remained unchanged. Debriefing surveys revealed overwhelming positive perceptions, with 97.9% of participants reporting improved understanding of roles, mutual respect, and enhanced teamwork. Students expressed greater confidence in interprofessional collaboration, emphasizing the experience's value despite occasional role ambiguity. Conclusion This deliberate, clinical IPE experience demonstrated significant benefits, including improved knowledge of pain management and positive attitudes toward interprofessional collaboration. Expanding similar initiatives can foster collaborative skills, fostering a comprehensive, interprofessional approach to patient care and addressing complex health care needs across diverse practice settings.

  PublisherOA PDFDOI

• The Role of Pharmacists in Mitigating Patient Harms and Drug Misinformation Risks Arising From Synthetic Smoke Shop Products

  JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · 2025-10-10 · 1 citations

  article1st author

  The authors declare no conflicts of interest.

  PublisherDOI

• The Impact of Diverse Kratom Products on Use Patterns, Dependence, and Toxicity

  Current Psychiatry Reports · 2025-08-05 · 7 citations

  review
  PublisherDOI

• Hemp-derived tetrahydrocannabinol (THC) and kratom related health claims provided by smoke shop employees: a secret shopper study

  The American Journal of Drug and Alcohol Abuse · 2025-05-22 · 3 citations

  article1st authorCorresponding

  Efforts to develop evidence-based consumer information regarding kratom and hemp-derived THC, improve health information provided by smoke shop employees, and incentivize store owners to devote resources to employee education are needed.

  PublisherDOI

• Comparing vape use and perceptions among pharmacy and non-pharmacy students from two universities in the US and UK

  PubMed · 2025-05-03

  articleOpen accessSenior author

  Introduction: Little research exists regarding pharmacy student vaping habits or differences among students from different countries. Methods: A novel 19-item questionnaire was distributed in November 2023 to students at The University of Bath (United Kingdom) and The University of Texas at Austin (United States) to compare vape use and perceptions among pharmacy and non-pharmacy students from the two universities. All pharmacy students at both institutions were invited to complete the survey. A non-pharmacy student control group was identified through snowball sampling (i.e., the survey was distributed to a convenience sample of non-pharmacy students at each school, asking them to complete and distribute to peers). To incentivize participation, one respondent received a $100 reward. Data was analyzed using descriptive statistics. Chi-square and Wilcoxon Rank Sum tests were used to compare answers between pharmacy and non-pharmacy and UK and US participants. A p-value < 0.05 was deemed significant. Results: Overall, 372 students completed the survey (25% pharmacy student response rate). Vape use significantly differed between pharmacy and non-pharmacy students (p = 0.03). Among 212 pharmacy students, 49% reported vape ever-use versus 59% of the 158 non-pharmacy students. Significant differences were found in harm perceptions; more pharmacy students believed vapes are cancer-causing, affect the health of others nearby, should be banned in public, and are ineffective for quitting cigarettes. Few differences were observed between UK and US students. Conclusion: Pharmacy students were less likely to vape and exhibited heightened awareness of associated risks than non-pharmacy students. Few differences were observed between UK and US students surveyed.

  PublisherOA PDFDOI

• Efficacy of Healthcare Student-Led Stop the Bleed Training for Middle School Students

  Disaster Medicine and Public Health Preparedness · 2025-01-01 · 2 citations

  articleOpen accessSenior authorCorresponding

  Abstract Objective Increase bleeding control knowledge and self-efficacy among middle school students and determine efficacy of health care student-led Stop the Bleed (STB) training. Methods An interprofessional group of health care students led STB trainings at 6 Texas middle schools. Trainings included a presentation plus hands-on skills training and were evaluated using pre- and post-training surveys focused on bleeding control knowledge, self-efficacy, and willingness to assist in emergencies. Paired pre- and post-training survey responses were compared using McNemar’s test for knowledge-based questions and paired t tests for Likert scale responses. Results Health care students ( N = 103) trained 805 middle school students, aged 10-16 years, of which 447 (55.5%) completed pre- and post-surveys. There was significant improvement in all 7 knowledge-based questions from pre- to post-training. There were significant improvements in comfort using tourniquets (median [interquartile range]: 3 [2-4] vs. 4 [3-5]; P &lt; 0.0001), confidence applying direct pressure (3 [2-4] vs. 4 [3-5]; P &lt; 0.0001), and likeliness to assist someone bleeding (4 [3-5] vs. 4 [4-5]; P = 0.0096). Eighty-four percent of students found this training “useful.” Conclusions While previous studies have demonstrated STB training efficacy, this is among the first to provide evidence that health care student-led STB training significantly increased bleeding control knowledge and self-efficacy among middle school students.

  PublisherOA PDFDOI

• Evidence Regarding E‐Cigarettes as a Harm Reduction Strategy and Treatment for E‐Cigarette Cessation: An Overview and Guide for Clinicians

  JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · 2025-07-31 · 1 citations

  articleOpen access1st authorCorresponding

  ABSTRACT Since their emergence on the United States market in the early 2000s, e‐cigarette accessibility and use have grown considerably. Electronic cigarettes (e‐cigarettes), also referred to as vapes or electronic nicotine delivery systems, deliver their contents by heating and aerosolizing an “e‐liquid” that is then inhaled. This differs from traditional tobacco cigarettes (TC), which rely on combustion, a process that is responsible for many of the deleterious effects of smoking. As a result, e‐cigarettes are viewed by some as a potential harm reduction tool for those interested in quitting smoking TC. However, others are concerned that increasing use, particularly among adolescents and young adults, may reverse decades of progress toward a tobacco‐free society and lead to greater harms. As e‐cigarette accessibility and use grow, clinicians will continue to encounter more patients using e‐cigarettes who may be seeking assistance in quitting; therefore, it is crucial that clinicians remain aware of the literature to provide complete and accurate information to patients. Current evidence suggests e‐cigarettes may be efficacious as a harm reduction tool for those not yet ready to completely abstain from nicotine. However, their relative addiction potential, lack of long‐term safety data, and known or suspected cardiovascular, pulmonary, and carcinogenic risks suggest that for most patients who are ready to stop using nicotine completely, the US Food and Drug Administration‐approved pharmacotherapy options should still be the recommended first‐line options. Ultimately, if e‐cigarettes are used as a tobacco cessation tool, patients should be advised that the end goal should be to quit using these products entirely. While there remains an unmet need for additional research into e‐cigarette cessation interventions, the existing evidence to date supports the use of partial nicotine receptor agonists such as varenicline to assist with cessation.

  PublisherOA PDFDOI

Frequent coauthors

• Kelly R. Reveles

  The University of Texas at Austin

  65 shared

• Alyssa M. Peckham

  Massachusetts General Hospital

  63 shared

• Christopher R. Frei

  The University of Texas Health Science Center at San Antonio

  57 shared

• Jordan R. Covvey

  Duquesne University

  35 shared

• Leslie Ochs

  New England College

  34 shared

• Sorina B. Torrez

  Austin College

  29 shared

• Lucas G. Hill

  The University of Texas at Austin

  25 shared

• Chengwen Teng

  22 shared